Professor João Pedro de Magalhães graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and in 2004 obtained a PhD in Biological Sciences from the University of Namur in Belgium.
Following further training in genetics at Harvard Medical School (Boston, USA), in 2008 Prof de Magalhães joined the University of Liverpool in the UK and established the Integrative Genomics of Ageing group
. His research on genetics, ageing and longevity has been widely featured in scientific magazines (Science, Nature, Scientific American, New Scientist, etc.), and he has published over 100 scientific papers.
Prof de Magalhães is a world-leader in big data and computational analyses, including genomics and machine learning, in ageing, longevity and age-related diseases. In addition, he has a longterm interest in technological trends and their future impact on society. His work on predicting how technology will shape the human condition has been published in magazines such as Futures and The Futurist, and in newspapers like The Independent.
Prof de Magalhães has given over 100 invited talks in international conferences, including three TEDx talks, and in many academic institutions and companies (e.g., Google's Calico and Allianz). He also makes regular media appearances (BBC, CNN, the Washington Post, the Financial Times and many others).
Prof de Magalhães is an advisor/consultant for various organizations, including nonprofit foundations and charities, universities, investment funds and biotech companies.
He is Chief Scientific Officer of Centaura
, an ambitious biotech company in Switzerland focused on healthy ageing, and founded his own his company Magellan Science Ltd.